Back to HomeBeta

ICD-10 Coding for Chronic Myelogenous Leukemia(C92.10, C92.11)

Complete ICD-10-CM coding and documentation guide for Chronic Myelogenous Leukemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Chronic Myeloid LeukemiaCML

Related ICD-10 Code Ranges

Complete code families applicable to Chronic Myelogenous Leukemia

C92.1-C92.12Primary Range

Chronic myelogenous leukemia, BCR/ABL-positive

This range covers all phases of CML, including chronic, accelerated, and blast crisis, with specific codes for remission status.

Atypical chronic myeloid leukemia, BCR/ABL-negative

This range is used for CML cases that are BCR/ABL-negative, requiring different diagnostic criteria.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C92.10Chronic myelogenous leukemia, BCR/ABL-positive, not having achieved remissionUse when CML is active and not in remission.
  • BCR/ABL1-positive confirmed by PCR or FISH
  • Elevated WBC count with basophilia
C92.11Chronic myelogenous leukemia, BCR/ABL-positive, in remissionUse when CML is in remission, confirmed by molecular testing.
  • BCR/ABL1-positive with molecular remission (≤0.1% IS)

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for chronic myelogenous leukemia

Essential facts and insights about Chronic Myelogenous Leukemia

The ICD-10 code for chronic myelogenous leukemia, BCR/ABL-positive, not in remission is C92.10. For CML in remission, use C92.11.

Primary ICD-10-CM Codes for chronic myelogenous leukemia

Chronic myelogenous leukemia, BCR/ABL-positive, not having achieved remission
Billable Code

Decision Criteria

clinical Criteria

  • BCR/ABL1-positive with active disease symptoms

Applicable To

  • Active CML, BCR/ABL-positive

Excludes

  • C92.20 (Atypical CML, BCR/ABL-negative)

Clinical Validation Requirements

  • BCR/ABL1-positive confirmed by PCR or FISH
  • Elevated WBC count with basophilia

Code-Specific Risks

  • Misclassification if remission status is not documented

Coding Notes

  • Ensure BCR/ABL-positive status is documented.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of leukemia

Z85.21
Use for patients in surveillance post-treatment.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Atypical chronic myeloid leukemia, BCR/ABL-negative

C92.20
Use when BCR/ABL-negative status is confirmed.

Chronic myelogenous leukemia, BCR/ABL-positive, not having achieved remission

C92.10
Use when CML is active and not in remission.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Chronic Myelogenous Leukemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C92.10.

Impact

Clinical: Inaccurate treatment monitoring, Regulatory: Non-compliance with coding standards, Financial: Potential for claim denials

Mitigation Strategy

Regularly update patient records with remission status, Train staff on documentation requirements

Impact

Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 specificity requirements., Data Quality: Poor data quality affecting clinical outcomes tracking.

Mitigation Strategy

Use C92.1x codes with specific documentation of BCR/ABL status and remission.

Impact

Inadequate documentation of remission status can lead to audit issues.

Mitigation Strategy

Implement regular audits of patient records for remission documentation.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Chronic Myelogenous Leukemia, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Chronic Myelogenous Leukemia

Use these documentation templates to ensure complete and accurate documentation for Chronic Myelogenous Leukemia. These templates include all required elements for proper coding and billing.

CML in remission

Specialty: Oncology

Required Elements

  • BCR/ABL1 status
  • Phase of disease
  • Current treatment

Example Documentation

Patient with CML, BCR/ABL1-positive, in molecular remission (0.08% IS), on imatinib.

Examples: Poor vs. Good Documentation

Poor Documentation Example
CML stable on therapy.
Good Documentation Example
CML BCR/ABL1+ in hematologic remission (WBC 8.2k/μL), MMR achieved (0.08% IS).
Explanation
The good example specifies remission status and molecular response.

Need help with ICD-10 coding for Chronic Myelogenous Leukemia? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more